Cargando…
Development, verification, and comparison of a risk stratification model integrating residual cancer burden to predict individual prognosis in early-stage breast cancer treated with neoadjuvant therapy
BACKGROUND: A favorable model for predicting disease-free survival (DFS) and stratifying prognostic risk in breast cancer (BC) treated with neoadjuvant chemotherapy (NAC) is lacking. The aim of the current study was to formulate an excellent model specially for predicting prognosis in these patients...
Autores principales: | Hou, N., Wu, J., Xiao, J., Wang, Z., Song, Z., Ke, Z., Wang, R., Wei, M., Xu, M., Wei, J., Qian, X., Xu, X., Yi, J., Wang, T., Zhang, J., Li, N., Fan, J., Hou, G., Wang, Y., Ling, R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8455687/ https://www.ncbi.nlm.nih.gov/pubmed/34537675 http://dx.doi.org/10.1016/j.esmoop.2021.100269 |
Ejemplares similares
-
Dose verification of helical tomotherapy intensity modulated radiation therapy planning using 2D-array ion chambers
por: Xu, S, et al.
Publicado: (2010) -
HPV-Associated Head and Neck Cancer: Molecular and Nano-Scale Markers for Prognosis and Therapeutic Stratification
por: Kimple, Adam J., et al.
Publicado: (2012) -
p62/SQSTM1 enhances breast cancer stem-like properties by stabilizing MYC mRNA
por: Xu, L-Z, et al.
Publicado: (2017) -
Residual cancer burden in locally advanced breast cancer: a superior tool
por: Nahleh, Z., et al.
Publicado: (2008) -
Symptom burden, psychological distress, and symptom management status in hospitalized patients with advanced cancer: a multicenter study in China
por: He, Y., et al.
Publicado: (2022)